Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

ATRC - AtriCure, Inc. So'nggi Yangiliklar | Finranks

Home

ATRC

A

AtriCure, Inc. (ATRC)

NGM – Real vaqt narxi. Valyuta: USD

28.88

-1.16 (-3.86%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

28.88

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 5:20 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?

AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?

ArtiCure Chief Science Officer sold 5,000 shares for a transaction value of approximately $149,000 at around $29.83 per share on March 12, 2026. The sale represented 4.91% of Vinayak's direct holdings, reducing direct ownership from 101,875 to 96,875 shares.

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure to Participate in the Citizens Life Sciences Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Citizens Life Sciences Conference. AtriCure's management is scheduled to participate in a fireside chat on Tuesday, March 10, 2026, at 1:05 p.m. Eastern Time. Interested parties may access a live audio.

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings

The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript

AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript

AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript

AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates

AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates

AtriCure (ATRC) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.08 per share a year ago.

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results. “Our 2025 performance reflects strong execution and continued momentum in our business. We delivered 15% revenue growth for the year and strengthened profitability while advancing key innovation and c.

Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know

Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know

AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Videolar

No Data

There is no data to display

Press-relizlar

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure to Participate in the Citizens Life Sciences Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Citizens Life Sciences Conference. AtriCure's management is scheduled to participate in a fireside chat on Tuesday, March 10, 2026, at 1:05 p.m. Eastern Time. Interested parties may access a live audio.

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results. “Our 2025 performance reflects strong execution and continued momentum in our business. We delivered 15% revenue growth for the year and strengthened profitability while advancing key innovation and c.

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the fourth quarter and full year 2025 and provided 2026 financial guidance. Preliminary, unaudited revenue for fourth quarter 2025 is expected to be $140.5 million, reflecting growth of approximately 13% over the fourth quar.

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming J.P. Morgan 44th Annual Healthcare Conference. AtriCure's management is scheduled to present on Wednesday, January 14, 2026, at 10:30 a.m. Pacific Standard Time. Interested parties may access a live aud.